Amedisys (NASDAQ:AMED) rose 1% in after hours trading after a divestiture agreement in its planned sale to UnitedHealth (NYSE ...

CAPNA hosts its Fourth Annual Health and Wellness Fair in Decatur on May 8, offering free health screenings and resources for ...

Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025. Three-Month Periods Ended March ...

Jeanne Whalen writes about the U.S. economy from the Chicago bureau. She previously covered healthcare, general news and ...

Additionally, the report highlights the termination of the Option Care Health, Inc. ("OPCH") Merger Agreement and the ...

Amedisys (Nasdaq: AMED) exceeded Wall Street expectations in its first-quarter results for 2025. The company’s home health segment benefited from ...

U.S. crude oil inventories rose for a fourth consecutive week amid higher net imports, while refineries ramped up their capacity use. Commercial crude oil stocks excluding the Strategic Petroleum ...

UnitedHealth faced a sharp decline following the release of its quarterly results, dropping 22.38% on April 17 and another ...

In a report released today, Matt Larew from William Blair maintained a Hold rating on Amedisys (AMED – Research Report). The company’s shares ...

Although the revenue and EPS for Amedisys (AMED) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street ...

Amedisys (AMED) delivered earnings and revenue surprises of 10.62% and 0%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Reports Q1 revenue $594.8M, consensus $596.49M.Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score ...